Novavax Inc
(NVAX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 18,662 | 34,288 | 31,176 | 15,353 | 36,250 |
| Gross Profit | 18,662 | 34,288 | 31,176 | 15,353 | 36,250 |
| Operating Expenses | 139,243 | 208,206 | 202,886 | 284,466 | 193,486 |
| Operating Income | -120,581 | -173,918 | -171,710 | -269,113 | -157,236 |
| Interest Expense | 13,612 | 13,612 | 14,072 | 12,965 | 241 |
| Other Income | 1,499 | 2,782 | 2,013 | 2,112 | 540 |
| Pre-tax Income | -132,694 | -184,748 | -183,769 | -279,966 | -156,937 |
| Net Income Continuous | -132,694 | -184,748 | -183,769 | -279,966 | -156,937 |
| Net Income | $-132,694 | $-184,748 | $-183,769 | $-279,966 | $-156,937 |
| EPS Basic Total Ops | -5.51 | -9.99 | -12.56 | -20.60 | -12.00 |
| EPS Basic Continuous Ops | -5.51 | -9.99 | -12.56 | -20.68 | -11.97 |
| EPS Diluted Total Ops | -5.51 | -9.99 | -12.56 | -20.60 | -12.00 |
| EPS Diluted Continuous Ops | -5.51 | -9.99 | -12.56 | -20.68 | -11.97 |
| EPS Diluted Before Non-Recurring Items | -5.80 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-114,905 | $-164,335 | $-160,469 | $-259,303 | $-151,253 |